Disulfiram and Chelated Zinc for the Rx of Disseminated Mets Mel That Has Failed First Line Therapy
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Primary Objectives Determine the response rate associated with treatment of refractory
disseminated malignant melanoma with disulfiram and chelated zinc.
Secondary Objectives Determine the progression-free survival associated with treatment of
refractory disseminated malignant melanoma with disulfiram and chelated zinc.
Determine the overall survival associated with treatment of refractory disseminated malignant
melanoma with disulfiram and chelated zinc.
Determine the toxicity associated with treatment of refractory disseminated malignant
melanoma with disulfiram and chelated zinc Determine the effect of disulfiram and chelated
zinc on in vivo protein S-glutathionylation.